TGF-β regulation of nuclear proto-oncogenes and TGF-β gene expression in normal human osteoblast-like cells

M. Subramaniam, Merry Jo Oursler, K. Rasmussen, B. L. Riggs, T. C. Spelsberg

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Transforming growth factor-β (TGF-β) is present in high levels in bone and plays an important role in osteoblast growth and differentiation. In order to dissect the molecular mechanisms of action of TGF-β on osteoblasts, the effects of TGF-β on the steady state mRNA levels of c-fos, c-jun, and jun-B proto-oncogenes on normal human osteoblast-like cells (hOB) and a transformed human osteoblast cell line (MG-63) were measured. Treatment of hOBs with 2 ng/ml of TGF-β1 resulted in a rapid increase in c-fos mRNA levels as early as 15 min post-treatment. A maximum (10-fold) increase was observed at 30 min after TGF-β treatment followed by a decrease to control values. Similar responses were measured whether the cells were rapidly proliferating or quiescent. TGF-β1 induced jun-B mRNA levels more gradually with steady increase initially observed at 30 min and a maximum induction measured at 2 h post-TGF-β treatment. In contrast, TGF-β treatment caused a time dependent decrease in the c-jun mRNA levels, an opposite pattern to that of jun-B mRNA. Treatment of hOBs with TGF-β1 in the presence of actinomycin-D abolished TGF-β1 induction of c-fos mRNA, suggesting that TGF-β action is mediated via transcription. In the presence of cycloheximide, TGF-β causes super-induction of c-fos mRNA at 30 min, indicating that the c-fos expression by TGF-β is independent of new protein synthesis. Further, transfection of 3 kb upstream region of jun-B promoter linked to a CAT reporter gene into ROS 17/2.8 cells was sufficient to be regulated by TGF-β1. Interestingly, TGF-β treatment also increased the mRNA levels of TGF-β1 itself at 4 h post TGF-β treatment, with a maximum increase observed at 14 h of treatment. TGF-β1 treatment for 30 min were sufficient to cause a delayed increase in TGF-β protein secretion within 24 h. These data support that TGF-β has major effects on hOB cell proto-oncogene expression and that the nuclear proto-oncogenes respond as rapid, early genes in a cascade model of hormone action.

Original languageEnglish (US)
Pages (from-to)52-61
Number of pages10
JournalJournal of Cellular Biochemistry
Volume57
Issue number1
DOIs
StatePublished - 1995

Fingerprint

Proto-Oncogenes
Osteoblasts
Transforming Growth Factors
Gene expression
Gene Expression
Messenger RNA
Genes
jun Genes

Keywords

  • C-fos
  • Jun-B
  • Osteoblasts
  • Promoter regulation
  • TGF-β

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology

Cite this

TGF-β regulation of nuclear proto-oncogenes and TGF-β gene expression in normal human osteoblast-like cells. / Subramaniam, M.; Oursler, Merry Jo; Rasmussen, K.; Riggs, B. L.; Spelsberg, T. C.

In: Journal of Cellular Biochemistry, Vol. 57, No. 1, 1995, p. 52-61.

Research output: Contribution to journalArticle

Subramaniam, M. ; Oursler, Merry Jo ; Rasmussen, K. ; Riggs, B. L. ; Spelsberg, T. C. / TGF-β regulation of nuclear proto-oncogenes and TGF-β gene expression in normal human osteoblast-like cells. In: Journal of Cellular Biochemistry. 1995 ; Vol. 57, No. 1. pp. 52-61.
@article{a29289de24234ab794ceaf1b4480f111,
title = "TGF-β regulation of nuclear proto-oncogenes and TGF-β gene expression in normal human osteoblast-like cells",
abstract = "Transforming growth factor-β (TGF-β) is present in high levels in bone and plays an important role in osteoblast growth and differentiation. In order to dissect the molecular mechanisms of action of TGF-β on osteoblasts, the effects of TGF-β on the steady state mRNA levels of c-fos, c-jun, and jun-B proto-oncogenes on normal human osteoblast-like cells (hOB) and a transformed human osteoblast cell line (MG-63) were measured. Treatment of hOBs with 2 ng/ml of TGF-β1 resulted in a rapid increase in c-fos mRNA levels as early as 15 min post-treatment. A maximum (10-fold) increase was observed at 30 min after TGF-β treatment followed by a decrease to control values. Similar responses were measured whether the cells were rapidly proliferating or quiescent. TGF-β1 induced jun-B mRNA levels more gradually with steady increase initially observed at 30 min and a maximum induction measured at 2 h post-TGF-β treatment. In contrast, TGF-β treatment caused a time dependent decrease in the c-jun mRNA levels, an opposite pattern to that of jun-B mRNA. Treatment of hOBs with TGF-β1 in the presence of actinomycin-D abolished TGF-β1 induction of c-fos mRNA, suggesting that TGF-β action is mediated via transcription. In the presence of cycloheximide, TGF-β causes super-induction of c-fos mRNA at 30 min, indicating that the c-fos expression by TGF-β is independent of new protein synthesis. Further, transfection of 3 kb upstream region of jun-B promoter linked to a CAT reporter gene into ROS 17/2.8 cells was sufficient to be regulated by TGF-β1. Interestingly, TGF-β treatment also increased the mRNA levels of TGF-β1 itself at 4 h post TGF-β treatment, with a maximum increase observed at 14 h of treatment. TGF-β1 treatment for 30 min were sufficient to cause a delayed increase in TGF-β protein secretion within 24 h. These data support that TGF-β has major effects on hOB cell proto-oncogene expression and that the nuclear proto-oncogenes respond as rapid, early genes in a cascade model of hormone action.",
keywords = "C-fos, Jun-B, Osteoblasts, Promoter regulation, TGF-β",
author = "M. Subramaniam and Oursler, {Merry Jo} and K. Rasmussen and Riggs, {B. L.} and Spelsberg, {T. C.}",
year = "1995",
doi = "10.1002/jcb.240570107",
language = "English (US)",
volume = "57",
pages = "52--61",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - TGF-β regulation of nuclear proto-oncogenes and TGF-β gene expression in normal human osteoblast-like cells

AU - Subramaniam, M.

AU - Oursler, Merry Jo

AU - Rasmussen, K.

AU - Riggs, B. L.

AU - Spelsberg, T. C.

PY - 1995

Y1 - 1995

N2 - Transforming growth factor-β (TGF-β) is present in high levels in bone and plays an important role in osteoblast growth and differentiation. In order to dissect the molecular mechanisms of action of TGF-β on osteoblasts, the effects of TGF-β on the steady state mRNA levels of c-fos, c-jun, and jun-B proto-oncogenes on normal human osteoblast-like cells (hOB) and a transformed human osteoblast cell line (MG-63) were measured. Treatment of hOBs with 2 ng/ml of TGF-β1 resulted in a rapid increase in c-fos mRNA levels as early as 15 min post-treatment. A maximum (10-fold) increase was observed at 30 min after TGF-β treatment followed by a decrease to control values. Similar responses were measured whether the cells were rapidly proliferating or quiescent. TGF-β1 induced jun-B mRNA levels more gradually with steady increase initially observed at 30 min and a maximum induction measured at 2 h post-TGF-β treatment. In contrast, TGF-β treatment caused a time dependent decrease in the c-jun mRNA levels, an opposite pattern to that of jun-B mRNA. Treatment of hOBs with TGF-β1 in the presence of actinomycin-D abolished TGF-β1 induction of c-fos mRNA, suggesting that TGF-β action is mediated via transcription. In the presence of cycloheximide, TGF-β causes super-induction of c-fos mRNA at 30 min, indicating that the c-fos expression by TGF-β is independent of new protein synthesis. Further, transfection of 3 kb upstream region of jun-B promoter linked to a CAT reporter gene into ROS 17/2.8 cells was sufficient to be regulated by TGF-β1. Interestingly, TGF-β treatment also increased the mRNA levels of TGF-β1 itself at 4 h post TGF-β treatment, with a maximum increase observed at 14 h of treatment. TGF-β1 treatment for 30 min were sufficient to cause a delayed increase in TGF-β protein secretion within 24 h. These data support that TGF-β has major effects on hOB cell proto-oncogene expression and that the nuclear proto-oncogenes respond as rapid, early genes in a cascade model of hormone action.

AB - Transforming growth factor-β (TGF-β) is present in high levels in bone and plays an important role in osteoblast growth and differentiation. In order to dissect the molecular mechanisms of action of TGF-β on osteoblasts, the effects of TGF-β on the steady state mRNA levels of c-fos, c-jun, and jun-B proto-oncogenes on normal human osteoblast-like cells (hOB) and a transformed human osteoblast cell line (MG-63) were measured. Treatment of hOBs with 2 ng/ml of TGF-β1 resulted in a rapid increase in c-fos mRNA levels as early as 15 min post-treatment. A maximum (10-fold) increase was observed at 30 min after TGF-β treatment followed by a decrease to control values. Similar responses were measured whether the cells were rapidly proliferating or quiescent. TGF-β1 induced jun-B mRNA levels more gradually with steady increase initially observed at 30 min and a maximum induction measured at 2 h post-TGF-β treatment. In contrast, TGF-β treatment caused a time dependent decrease in the c-jun mRNA levels, an opposite pattern to that of jun-B mRNA. Treatment of hOBs with TGF-β1 in the presence of actinomycin-D abolished TGF-β1 induction of c-fos mRNA, suggesting that TGF-β action is mediated via transcription. In the presence of cycloheximide, TGF-β causes super-induction of c-fos mRNA at 30 min, indicating that the c-fos expression by TGF-β is independent of new protein synthesis. Further, transfection of 3 kb upstream region of jun-B promoter linked to a CAT reporter gene into ROS 17/2.8 cells was sufficient to be regulated by TGF-β1. Interestingly, TGF-β treatment also increased the mRNA levels of TGF-β1 itself at 4 h post TGF-β treatment, with a maximum increase observed at 14 h of treatment. TGF-β1 treatment for 30 min were sufficient to cause a delayed increase in TGF-β protein secretion within 24 h. These data support that TGF-β has major effects on hOB cell proto-oncogene expression and that the nuclear proto-oncogenes respond as rapid, early genes in a cascade model of hormone action.

KW - C-fos

KW - Jun-B

KW - Osteoblasts

KW - Promoter regulation

KW - TGF-β

UR - http://www.scopus.com/inward/record.url?scp=0028950494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028950494&partnerID=8YFLogxK

U2 - 10.1002/jcb.240570107

DO - 10.1002/jcb.240570107

M3 - Article

C2 - 7721958

AN - SCOPUS:0028950494

VL - 57

SP - 52

EP - 61

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 1

ER -